159 related articles for article (PubMed ID: 24802710)
1. Regulation of keratinocyte differentiation by O-GlcNAcylation.
Sohn KC; Lee EJ; Shin JM; Lim EH; No Y; Lee JY; Yoon TY; Lee YH; Im M; Lee Y; Seo YJ; Lee JH; Kim CD
J Dermatol Sci; 2014 Jul; 75(1):10-5. PubMed ID: 24802710
[TBL] [Abstract][Full Text] [Related]
2. Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.
Goldberg HJ; Whiteside CI; Hart GW; Fantus IG
Endocrinology; 2006 Jan; 147(1):222-31. PubMed ID: 16365142
[TBL] [Abstract][Full Text] [Related]
3. Terminal differentiation program of skeletal myogenesis is negatively regulated by O-GlcNAc glycosylation.
Ogawa M; Mizofuchi H; Kobayashi Y; Tsuzuki G; Yamamoto M; Wada S; Kamemura K
Biochim Biophys Acta; 2012 Jan; 1820(1):24-32. PubMed ID: 22056510
[TBL] [Abstract][Full Text] [Related]
4. O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis.
Tardio L; Andrés-Bergós J; Zachara NE; Larrañaga-Vera A; Rodriguez-Villar C; Herrero-Beaumont G; Largo R
Osteoarthritis Cartilage; 2014 Feb; 22(2):259-63. PubMed ID: 24333294
[TBL] [Abstract][Full Text] [Related]
5. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability.
Yang X; Su K; Roos MD; Chang Q; Paterson AJ; Kudlow JE
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6611-6. PubMed ID: 11371615
[TBL] [Abstract][Full Text] [Related]
6. Role of O-linked beta-N-acetylglucosamine modification in the subcellular distribution of alpha4 phosphoprotein and Sp1 in rat lymphoma cells.
Dauphinee SM; Ma M; Too CK
J Cell Biochem; 2005 Oct; 96(3):579-88. PubMed ID: 16052526
[TBL] [Abstract][Full Text] [Related]
7. Characteristic increase in nucleocytoplasmic protein glycosylation by O-GlcNAc in 3T3-L1 adipocyte differentiation.
Ishihara K; Takahashi I; Tsuchiya Y; Hasegawa M; Kamemura K
Biochem Biophys Res Commun; 2010 Jul; 398(3):489-94. PubMed ID: 20599697
[TBL] [Abstract][Full Text] [Related]
8. Measuring O-GlcNAc cleavage by OGA and cell lysates on a peptide microarray.
Sharif S; Shi J; Bourakba M; Ruijtenbeek R; Pieters RJ
Anal Biochem; 2017 Sep; 532():12-18. PubMed ID: 28571750
[TBL] [Abstract][Full Text] [Related]
9. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
Chung SS; Kim JH; Park HS; Choi HH; Lee KW; Cho YM; Lee HK; Park KS
Biochem Biophys Res Commun; 2008 Aug; 372(4):713-8. PubMed ID: 18513490
[TBL] [Abstract][Full Text] [Related]
10. Glucosamine-induced Sp1 O-GlcNAcylation ameliorates hypoxia-induced SGLT dysfunction in primary cultured renal proximal tubule cells.
Suh HN; Lee YJ; Kim MO; Ryu JM; Han HJ
J Cell Physiol; 2014 Oct; 229(10):1557-68. PubMed ID: 24591095
[TBL] [Abstract][Full Text] [Related]
11. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
Belke DD
J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAcylation increases non-amyloidogenic processing of the amyloid-β precursor protein (APP).
Jacobsen KT; Iverfeldt K
Biochem Biophys Res Commun; 2011 Jan; 404(3):882-6. PubMed ID: 21182826
[TBL] [Abstract][Full Text] [Related]
13. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
[TBL] [Abstract][Full Text] [Related]
14. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer.
Phueaouan T; Chaiyawat P; Netsirisawan P; Chokchaichamnankit D; Punyarit P; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2013 Dec; 30(6):2929-36. PubMed ID: 24126823
[TBL] [Abstract][Full Text] [Related]
15. The Sulfur-Linked Analogue of O-GlcNAc (S-GlcNAc) Is an Enzymatically Stable and Reasonable Structural Surrogate for O-GlcNAc at the Peptide and Protein Levels.
De Leon CA; Levine PM; Craven TW; Pratt MR
Biochemistry; 2017 Jul; 56(27):3507-3517. PubMed ID: 28627871
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcylation of Sp1 interrupts Sp1 interaction with NF-Y.
Lim K; Chang HI
Biochem Biophys Res Commun; 2009 May; 382(3):593-7. PubMed ID: 19302979
[TBL] [Abstract][Full Text] [Related]
17. High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.
Walgren JL; Vincent TS; Schey KL; Buse MG
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E424-34. PubMed ID: 12397027
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAc modification of Sp1 inhibits the functional interaction between Sp1 and Oct1.
Lim K; Chang HI
FEBS Lett; 2009 Feb; 583(3):512-20. PubMed ID: 19070619
[TBL] [Abstract][Full Text] [Related]
19. Neuronatin is related to keratinocyte differentiation by up-regulating involucrin.
Dugu L; Nakahara T; Wu Z; Uchi H; Liu M; Hirano K; Yokomizo T; Furue M
J Dermatol Sci; 2014 Mar; 73(3):225-31. PubMed ID: 24252747
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAc modification modulates the expression of osteocalcin via OSE2 and Runx2.
Kim SH; Kim YH; Song M; An SH; Byun HY; Heo K; Lim S; Oh YS; Ryu SH; Suh PG
Biochem Biophys Res Commun; 2007 Oct; 362(2):325-9. PubMed ID: 17707335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
